Dr. Andrew Kent, MD, PhD
Claim this profileStudies Acute Myeloid Leukemia
Studies T-Lymphoblastic Leukemia/Lymphoma
1 reported clinical trial
1 drug studied
Clinical Trials Andrew Kent, MD, PhD is currently running
More about Andrew Kent, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Andrew Kent, MD, PhD has experience with
- Mitoxantrone
Breakdown of trials Andrew Kent, MD, PhD has run
Acute Myeloid Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Kent, MD, PhD specialize in?
Andrew Kent, MD, PhD focuses on Acute Myeloid Leukemia and T-Lymphoblastic Leukemia/Lymphoma. In particular, much of their work with Acute Myeloid Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Andrew Kent, MD, PhD currently recruiting for clinical trials?
Yes, Andrew Kent, MD, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Andrew Kent, MD, PhD has studied deeply?
Yes, Andrew Kent, MD, PhD has studied treatments such as Mitoxantrone.
What is the best way to schedule an appointment with Andrew Kent, MD, PhD?
Apply for one of the trials that Andrew Kent, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.